MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3324/haematol.2009.008862

Медицинская библиотека · Haematologica · 2009

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.

Bernd Heinz-Wolfram, Ziepert Marita, Thorns Christoph, Klapper Wolfram, Wacker Hans-Heinrich, Hummel Michael, Stein Harald, Hansmann Martin-Leo, Ott German, Rosenwald Andreas, Müller-Hermelink Hans-Konrad, Barth Thomas F E, Möller Peter, Cogliatti Sergio B, Pfreundschuh Michael, Schmitz Norbert, Trümper Lorenz, Höller Silvia, Löffler Markus, Feller Alfred C, German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Research on prognostically relevant immunohistochemical markers in diffuse large B-cell lymphomas has mostly been performed on retrospectively collected clinical data. This is also true for immunohistochemical classifiers that are thought to reflect the cell-of-origin subclassification of gene expression studies. In order to obtain deeper insight into the heterogeneous prognosis of diffuse large B-cell lymphomas and to validate a previously published immunohistochemical classifier, we analyzed data from a large set of cases from prospective clinical trials with long-term follow-up.

DESIGN AND

METHODS

We performed morphological and extensive immunohistochemical analyses in 414 cases of diffuse large B-cell lymphoma from two prospective randomized clinical trials (NHL-B1/B2, Germany). Classification into germinal center and non-germinal center subtypes of B-cell lymphoma was based on the expression pattern of CD10, BCL6, and IRF4. Multivariate analyses were performed adjusting for the factors in the International Prognostic Index.

RESULTS

Analyzing 20 different epitopes on tissue microarrays, expression of HLA-DR, presence of CD23(+) follicular dendritic cell meshworks, and monotypic light chain expression emerged as International Prognostic Index-independent markers of superior overall survival. Immunoblastic morphology was found to be related to poor event-free survival. The non-germinal center subtype, according to the three-epitope classifier (CD10, BCL6, and IRF4) did not have prognostic relevance when adjusted for International Prognostic Index factors (relative risk=1.2, p=0.328 for overall survival; and relative risk=1.1, p=0.644 for event-free survival).

CONCLUSIONS

The previously reported International Prognostic Index-independent prognostic value of stratification into germinal center/non-germinal center B-cell lymphoma using the expression pattern of CD10, BCL6, and IRF4 was not reproducible in our series. However, other markers and the morphological subtype appear to be of prognostic value.

Для цитирования: Bernd Heinz-Wolfram, Ziepert Marita, Thorns Christoph, Klapper Wolfram, Wacker Hans-Heinrich, Hummel Michael, Stein Harald, Hansmann Martin-Leo, Ott German, Rosenwald Andreas, Müller-Hermelink Hans-Konrad, Barth Thomas F E, Möller Peter, Cogliatti Sergio B, Pfreundschuh Michael, Schmitz Norbert, Trümper Lorenz, Höller Silvia, Löffler Markus, Feller Alfred C, German High Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.. Haematologica. 2009. DOI: 10.3324/haematol.2009.008862.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.